United Therapeutics Corporation announced that it will report its second quarter 2018 financial results before the market opens on Wednesday, August 1, 2018.
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 26, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2018 financial results before the market opens on Wednesday, August 1, 2018.
United Therapeutics will host a teleconference on Wednesday, August 1, 2018, at 9:00 a.m. Eastern Time. The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using access code: 4434188.
This teleconference is also being webcast and can be accessed via United Therapeutics’ website at http://ir.unither.com/events.cfm. [uthr-g]
About United Therapeutics
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions.
View original content:http://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-report-second-quarter-2018-financial-results-before-the-market-opens-on-wednesday-august-1-2018-300686744.html
SOURCE United Therapeutics Corporation
Company Codes: NASDAQ-NMS:UTHR